The effectiveness of a self-stigma reduction intervention upon stigma measures for patients with tuberculosis (TB) and multidrug-resistant tuberculosis (MDR-TB) in Vietnam: a randomised controlled trial

Not Applicable

• Conditions: Mental Health - Depression; stigma; depression; tuberculosis; Public Health - Health promotion/education; Infection - Other infectious diseases; multidrug-resistant tuberculosis

• Registration Number: ACTRN12619000949189
• Lead Sponsor: niversity of Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-07-05
• Last Update Posted: 15 July 2019

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 268

Inclusion Criteria

Patients with bacteriologically proven pulmonary TB and Patients with bacteriologically proven pulmonary RR/MDR-TB, be undertaking treatment for within the NTP at the participating health facilities and be considered as non-infectious will be eligible to participate. To be considered as non-infectious, they require 1) reduction in symptoms AND, 2) reduction in smear grade, culture negative for last 4 weeks OR unable to produce sputum AND 3) completed at least 2 weeks of treatment for patients with TB or 6 weeks of treatment for patients with RR/MDR-TB.

Exclusion Criteria

Unable to participate in the intervention
People that are incarcerated
Do not live in the study location, Hanoi, Vietnam

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluate the effect of a self-stigma and shame workshop (the intervention) upon the self-stigma of patients with RR/MDR-TB, measured according to a validated self-stigma scale (the Redwood self-stigma subscale).[4 months after baseline. The intervention will be delivered between baseline and 2 months.];Evaluate the effect of the intervention upon the measured stigma of patients with new TB, measured according to a validated self-stigma scale (the Redwood self-stigma subscale).[4 months after baseline. The intervention will be delivered between baseline and 2 months.]